PG's and Keratinocyte Adhesion
PG 和角质形成细胞粘附
基本信息
- 批准号:7686824
- 负责人:
- 金额:$ 13.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-12 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdhesionsAdhesivesAgonistAnimal ModelAwardAwarenessBasic ScienceCadherin DomainCancer BiologyCancer EtiologyCell Adhesion MoleculesCell surfaceCellsChronicClinicalClinical TrialsCoupledCytokeratinCytoplasmDeformityDevelopmentDevelopment PlansDinoprostoneDoctor of MedicineDoseDown-RegulationE-CadherinEducational CurriculumEmergency MedicineEndocytosisEpithelialEpithelial CellsEventExposure toGeneticGoalsGrantHealthcareHumanIn VitroInbred HRS MiceIncidenceInjuryInstitutionInterventionInvadedKineticsKnockout MiceLaboratoriesLeadLoss of E-cadherin ExpressionLysosomesMalignant - descriptorMalignant NeoplasmsMatrix MetalloproteinasesMeasuresMediatingMedicalMembrane GlycoproteinsMentorshipMessenger RNAModelingMorbidity - disease rateMusNatureOncogenicPathway interactionsPhenotypeProcessProliferatingProteinsRadiation InjuriesReceptor SignalingRecruitment ActivityResearchResearch PersonnelRoleRouteScientistSkin CancerSkin NeoplasmsSquamous cell carcinomaStimulusTestingTimeTrainingTraining SupportTransgenic MiceTranslational ResearchTumor Cell LineUV inducedUbiquitinationUltraviolet RaysUnited States National Institutes of HealthUniversitiesbasebench to bedsidebutaprostcareercareer developmentclinical practicecostcyclooxygenase 2designextracellularhuman tissueinhibitor/antagonistkeratinocytemedical schoolsmortalitymouse modelmulticatalytic endopeptidase complexneoplasticnovelpreclinical studyprofessorprogramsprostaglandin EP2 receptorreceptorresearch studyskin lesionteachertissue culturetraffickingtumortumor progressiontumorigenesistumorigenicultravioletultraviolet irradiation
项目摘要
DESCRIPTION (provided by applicant): The candidate's goal is to advance her academic career by becoming a translational scientist through additional basic research and didactic training supported by a K08 Clinician-Scientist Development Award. The candidate is an Assistant Professor in the Clinician-Research-Teacher tenure-track at the University of Rochester School of Medicine, Department of Emergency Medicine. The candidate graduated from medical school in 1998 receiving an M.D. with Distinctions in Research, and since has successfully combined postdoctoral studies in basic research (80% effort) with clinical practice (20% effort). To reach her professional goal, the candidate proposes here a career development plan that will enable her to obtain additional training through coursework specifically designed to educate translational scientists as part of the curriculum available by the recently awarded CTSA NIH grant to our Institution. Moreover, the candidate will continue to pursue her successful research plan in skin cancer biology, coupled with advanced level courses in basic sciences. To this end, the candidate has discovered that in UV-induced skin cancers, the facilitative (pro-oncogenic) down-regulation of E-cadherin, an adhesion molecule mediating cell-cell contacts between keratinocytes, is a post-translational event consisting first of extracellular E-cadherin domain cleavage (primarily by MMPs), followed by endocytosis and proteolytic/ lysosomal-proteasomal degradation. Moreover, the candidate has discovered that this process is regulated by activation of the EP2 receptor by PGE2 released locally after UV radiation injury. As part of this K08 award, the candidate will continue her studies on this topic, which ultimately will lead to the identification of new targets for pharmacological intervention against UV-induced skin cancers. Completion of the proposed plan will enable the candidate to receive a Master's in Translational Science degree as part of her K08 award. Due to the diverse nature of the proposed training, the candidate has recruited a mentorial committee that provides the necessary mentorship, expertise and support. In conclusion, this K08 award will prepare the candidate for a career in basic/translational science, whereby she will be able to (1) identify novel scientific discoveries and their potential clinical usefulness in animal models (preclinical studies) in the laboratory, (2) evaluate such discoveries through clinical trials, and (3) bring their use to clinical practice (bench-to-bedside-to-curb).
描述(由申请人提供):候选人的目标是通过 K08 临床医生-科学家发展奖支持的额外基础研究和教学培训,成为一名转化科学家,从而推进她的学术生涯。该候选人是罗彻斯特大学医学院急诊医学系的临床医生-研究-教师终身教授助理教授。该候选人于 1998 年从医学院毕业,获得研究杰出医学博士学位,此后成功地将基础研究(80% 努力)的博士后研究与临床实践(20% 努力)结合起来。为了实现她的职业目标,候选人在此提出了一个职业发展计划,该计划将使她能够通过专门为教育转化科学家而设计的课程获得额外的培训,作为最近授予我们机构的 CTSA NIH 拨款提供的课程的一部分。此外,候选人将继续追求她在皮肤癌生物学方面的成功研究计划,以及基础科学的高级课程。为此,候选人发现,在紫外线诱导的皮肤癌中,E-钙粘蛋白(一种介导角质形成细胞之间细胞间接触的粘附分子)的促进(促癌)下调是一个翻译后事件,首先包括细胞外 E-钙粘蛋白结构域裂解(主要通过 MMP),然后是胞吞作用和蛋白水解/溶酶体-蛋白酶体降解。此外,该候选人还发现,这一过程是通过紫外线辐射损伤后局部释放的 PGE2 激活 EP2 受体来调节的。作为 K08 奖项的一部分,候选人将继续对该主题的研究,最终将确定针对紫外线诱发的皮肤癌的药物干预的新靶标。完成拟议计划将使候选人获得转化科学硕士学位,作为其 K08 奖项的一部分。由于拟议培训的多样性,候选人已招募了一个指导委员会来提供必要的指导、专业知识和支持。总之,该 K08 奖项将为候选人在基础/转化科学领域的职业生涯做好准备,她将能够 (1) 识别新颖的科学发现及其在实验室动物模型(临床前研究)中的潜在临床用途,(2 )通过临床试验评估这些发现,以及(3)将其应用到临床实践(从实验室到床边到路边)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sabine M Brouxhon其他文献
Sabine M Brouxhon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sabine M Brouxhon', 18)}}的其他基金
A novel multi-targeted therapy for breast cancer resistance
一种新型多靶点乳腺癌耐药疗法
- 批准号:
9111810 - 财政年份:2016
- 资助金额:
$ 13.11万 - 项目类别:
A novel multi-targeted therapy for breast cancer resistance
一种新型多靶点乳腺癌耐药疗法
- 批准号:
8958353 - 财政年份:2015
- 资助金额:
$ 13.11万 - 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
- 批准号:
10474581 - 财政年份:2015
- 资助金额:
$ 13.11万 - 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
- 批准号:
8962751 - 财政年份:2015
- 资助金额:
$ 13.11万 - 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
- 批准号:
10249513 - 财政年份:2015
- 资助金额:
$ 13.11万 - 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
- 批准号:
10356177 - 财政年份:2015
- 资助金额:
$ 13.11万 - 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
- 批准号:
9333095 - 财政年份:2015
- 资助金额:
$ 13.11万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 13.11万 - 项目类别:
Developing novel therapies to improve blood stem cell transplantation outcomes
开发新疗法以改善造血干细胞移植结果
- 批准号:
10830194 - 财政年份:2023
- 资助金额:
$ 13.11万 - 项目类别:
Elucidating the role of Myosin 5b in intestinal inflammation
阐明肌球蛋白 5b 在肠道炎症中的作用
- 批准号:
10883872 - 财政年份:2023
- 资助金额:
$ 13.11万 - 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
- 批准号:
10606952 - 财政年份:2023
- 资助金额:
$ 13.11万 - 项目类别:
Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity
CAR T 细胞治疗相关神经毒性中的内皮-白细胞粘附
- 批准号:
10735681 - 财政年份:2023
- 资助金额:
$ 13.11万 - 项目类别: